S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Tabula Rasa HealthCare Stock Forecast, Price & News

+0.02 (+0.78%)
(As of 07/1/2022 08:45 PM ET)
Today's Range
50-Day Range
52-Week Range
417,900 shs
Average Volume
816,255 shs
Market Capitalization
$66.95 million
P/E Ratio
Dividend Yield
Price Target

Tabula Rasa HealthCare MarketRank™ Forecast

Analyst Rating
2.29 Rating Score
401.9% Upside
$13.00 Price Target
Short Interest
9.86% of Float Sold Short
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth
From ($1.65) to ($1.20) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.76 out of 5 stars

Medical Sector

779th out of 1,412 stocks

Business Services, Not Elsewhere Classified Industry

72nd out of 145 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

Tabula Rasa HealthCare logo

About Tabula Rasa HealthCare (NASDAQ:TRHC) Stock

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

TRHC Stock News Headlines

Continuing To Avoid Tabula Rasa HealthCare Inc.
4 Analysts Have This to Say About Tabula Rasa HealthCare
Tabula Rasa HealthCare to sell DoseMeRx solution
Tabula Rasa Healthcare to Sell DoseMeRx
See More Headlines

Industry, Sector and Symbol

Business services, not elsewhere classified
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$-79.06 million
Pretax Margin


Sales & Book Value

Annual Sales
$331.26 million
Cash Flow
$0.24 per share
Book Value
$2.17 per share


Free Float
Market Cap
$66.95 million

Tabula Rasa HealthCare Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Tabula Rasa HealthCare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View analyst ratings for Tabula Rasa HealthCare
or view top-rated stocks.

What is Tabula Rasa HealthCare's stock price forecast for 2022?

7 equities research analysts have issued twelve-month price objectives for Tabula Rasa HealthCare's stock. Their TRHC stock forecasts range from $5.00 to $23.00. On average, they predict Tabula Rasa HealthCare's share price to reach $13.00 in the next year. This suggests a possible upside of 401.9% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
or view top-rated stocks among Wall Street analysts.

How has Tabula Rasa HealthCare's stock performed in 2022?

Tabula Rasa HealthCare's stock was trading at $15.00 on January 1st, 2022. Since then, TRHC shares have decreased by 82.7% and is now trading at $2.59.
View the best growth stocks for 2022 here

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Tabula Rasa HealthCare

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings results on Thursday, May, 5th. The company reported ($0.69) earnings per share for the quarter, missing analysts' consensus estimates of ($0.47) by $0.22. The business had revenue of $67.11 million for the quarter, compared to analysts' expectations of $84.88 million. Tabula Rasa HealthCare had a negative trailing twelve-month return on equity of 84.40% and a negative net margin of 27.28%.
View Tabula Rasa HealthCare's earnings history

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its second quarter 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $66.00 million-$69.00 million, compared to the consensus revenue estimate of $91.40 million.

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D., Co-Founder, Chairman & CEO (Age 72, Pay $742.42k)
  • Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 53, Pay $563.79k)
  • Mr. Brian W. Adams, Co-Pres & Sec. (Age 40, Pay $515.63k) (LinkedIn Profile)
  • Mr. Michael Greenhalgh, Chief Operating Officer (Age 60, Pay $507.79k) (LinkedIn Profile)
  • Mr. Thomas J. Cancro C.F.A., CPA, Chief Financial Officer (Age 54)
  • Ms. Andrea Carolan Speers M.S., Corp. Controller & Chief Accounting Officer (Age 41)
  • Mr. Bob Sullivan M.S., Chief Technology Officer
  • Dr. Jacques Turgeon B.Pharm., Ph.D., Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute (Age 62)
  • Mr. Phillip W. Heath MS, Chief Admin. Officer (Age 56)
  • Mr. Frank Sparacino C.F.A., CPA, Sr. VP of Investor Relations & Corp. Devel.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare CEO Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among Tabula Rasa HealthCare's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), (CGC), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $2.59.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $66.95 million and generates $331.26 million in revenue each year. The company earns $-79.06 million in net income (profit) each year or ($3.730010) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

Tabula Rasa HealthCare employs 1,602 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.

This page (NASDAQ:TRHC) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.